.Pharmacolibrary.Drugs.ATC.V.V03AF08 .Pharmacolibrary.Drugs.ATC.V.V03AF08| name: | Palifermin |
| ATC code: | V03AF08 | route: | intravenous |
| n-compartments | 2 |
Palifermin is a recombinant human keratinocyte growth factor (KGF) that is used to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies undergoing high-dose chemotherapy and stem cell transplantation. It is FDA approved and in current clinical use.
Pharmacokinetic parameters reported in adults with hematologic malignancies receiving high-dose chemotherapy and hematopoietic stem cell transplantation.